What conditions are treated with Ustekinumab?
Psoriasis and psoriatic arthritis.
What are the uses of Azathioprine?
Rheumatoid arthritis and prevention of organ transplant rejection.
1/53
p.3
Biologic DMARDs Overview

What conditions are treated with Ustekinumab?

Psoriasis and psoriatic arthritis.

p.1
Uses of Conventional Synthetic DMARDs

What are the uses of Azathioprine?

Rheumatoid arthritis and prevention of organ transplant rejection.

p.3
Immunosuppressive Properties of DMARDs

Name some immunosuppressors mentioned.

Azathioprine, Cyclosporine, Mycophenolate Mofetil, Abatacept, and Tofacitinib.

p.2
Toxicities and Risks of DMARDs

What is a significant risk of Rituximab?

High risk of hypersensitivity and may reactivate Hepatitis B.

p.3
Biologic DMARDs Overview

What does Secukinumab selectively bind to?

IL-17A.

p.2
Toxicities and Risks of DMARDs

What is a notable side effect of Azathioprine?

Gingival hyperplasia.

p.1
Uses of Conventional Synthetic DMARDs

What are the uses of Chloroquine?

Rheumatoid arthritis and malaria (in areas not resistant to chloroquine).

p.2
Biologic DMARDs: Abatacept, Rituximab, and Tocilizumab

What is the mechanism of action of Tocilizumab?

Binds IL-6 receptor, inhibiting IL-6 mediated signaling.

p.3
TNF-alpha Blockers and their Applications

What conditions are treated with TNF-alpha blockers?

Rheumatoid arthritis and inflammatory bowel disease.

p.2
Specific DMARDs: Azathioprine, Cyclophosphamide, and Cyclosporine

What is the mechanism of action of Azathioprine?

Inhibits macrophage-T cell interaction and T-cell responsiveness.

p.1
Considerations for DMARD Therapy in Special Populations

What should Azathioprine not be taken with?

Allopurinol.

p.1
Toxicities and Risks of DMARDs

What is a significant risk associated with Cyclophosphamide?

Hemorrhagic cystitis due to accumulation of acrolein.

p.2
Toxicities and Risks of DMARDs

What are some side effects of Sulfasalazine?

Hypersensitivity reactions, hemolytic anemia, and reversible infertility in men.

p.3
TNF-alpha Blockers and their Applications

What do TNF-alpha blockers bind to?

TNF-alpha.

p.3
Specific DMARDs: Azathioprine, Cyclophosphamide, and Cyclosporine

What does Tofacitinib inhibit?

Janus kinase.

p.2
Specific DMARDs: Azathioprine, Cyclophosphamide, and Cyclosporine

What does Leflunomide inhibit?

Dihydroorotate dehydrogenase.

p.1
Mechanism of Action of DMARDs

What is the mechanism of action of Cyclophosphamide?

Phosphoramide mustard binds DNA, preventing cell replication and suppressing T and B-cell function.

p.1
Uses of Conventional Synthetic DMARDs

What is the first-line use of Methotrexate?

Rheumatoid arthritis.

p.3
Biologic DMARDs Overview

What do IL-1 inhibitors act as?

IL-1 antagonists.

p.2
Uses of Conventional Synthetic DMARDs

How often is Leflunomide administered?

Once a week or every 2 weeks.

p.2
Uses of Conventional Synthetic DMARDs

What conditions is Sulfasalazine used to treat?

Rheumatoid arthritis and inflammatory bowel disease.

p.2
Uses of Conventional Synthetic DMARDs

What conditions is Tocilizumab used for?

Rheumatoid arthritis and COVID-19.

p.3
TNF-alpha Blockers and their Applications

What is the effect of TNF-alpha blockers on macrophage and T-cell function?

They downregulate macrophage and T-cell function.

p.1
Toxicities and Risks of DMARDs

What rescue agent is given with Methotrexate to mitigate toxicity?

Leucovorin (Folinic acid).

p.3
Biologic DMARDs Overview

What condition is treated with IL-1 inhibitors?

Rheumatoid arthritis.

p.2
Uses of Conventional Synthetic DMARDs

What conditions is Mycophenolate Mofetil used for?

Rheumatoid arthritis, SLE, and vasculitis.

p.1
Toxicities and Risks of DMARDs

What is a notable side effect of Cyclosporine?

Hirsutism.

p.3
Toxicities and Risks of DMARDs

What precaution should be taken due to potential cardiotoxicity of TNF-alpha blockers?

Perform a 2D echo.

p.3
Specific DMARDs: Azathioprine, Cyclophosphamide, and Cyclosporine

What is a major use of Tofacitinib?

Prevention of organ transplant rejection.

p.2
Specific DMARDs: Azathioprine, Cyclophosphamide, and Cyclosporine

What is the effect of Leflunomide on T-cell proliferation?

Decreased T-cell proliferation and decreased antibody production by B-cells.

p.2
Toxicities and Risks of DMARDs

What is a significant risk associated with Mycophenolate Mofetil?

Reversible myelosuppression and hepatotoxicity.

p.2
Biologic DMARDs: Abatacept, Rituximab, and Tocilizumab

What is the mechanism of action of Abatacept?

Binds to CD80 and CD86, inhibiting CD28 and T-cell production.

p.3
Biologic DMARDs Overview

What condition may Secukinumab exacerbate?

Crohn’s disease.

p.1
Toxicities and Risks of DMARDs

What is a notable toxicity of Chloroquine?

Ocular toxicity (corneal and retinal pigmentation).

p.2
Toxicities and Risks of DMARDs

What is a risk associated with Tocilizumab?

May reactivate latent TB.

p.3
Biologic DMARDs Overview

What is Ustekinumab an antagonist of?

IL-12 and IL-23.

p.2
Specific DMARDs: Azathioprine, Cyclophosphamide, and Cyclosporine

What condition is Azathioprine used to prevent?

Organ transplant rejection.

p.1
Mechanism of Action of DMARDs

What is the mechanism of action of Chloroquine?

Inhibits DNA and RNA synthesis and binds free radicals.

p.2
Specific DMARDs: Azathioprine, Cyclophosphamide, and Cyclosporine

What does Sulfasalazine inhibit?

Sulfapyridine, leading to inhibition of inflammatory cytokine release.

p.2
Toxicities and Risks of DMARDs

What is a risk associated with Abatacept?

Increased risk of infection and may reactivate latent TB and Hepatitis B.

p.1
Toxicities and Risks of DMARDs

What is a significant toxicity associated with Methotrexate?

Hepatotoxicity.

p.1
Toxicities and Risks of DMARDs

What is a significant risk associated with Azathioprine?

Increased incidence of lymphoma.

p.2
Specific DMARDs: Azathioprine, Cyclophosphamide, and Cyclosporine

What does Mycophenolate Mofetil inhibit?

Cyclophosphamide monophosphate dehydrogenase.

p.1
Mechanism of Action of DMARDs

What is the mechanism of action of Methotrexate?

Inhibits Aminoimidazole carboxamide ribonucleotide (AICAR) transformylase and Thymidylate synthase, leading to increased adenosine and inhibition of inflammation and chemotaxis of PMNs.

p.3
Toxicities and Risks of DMARDs

Who should not be given Tofacitinib?

Patients with severe hepatic disease.

p.2
Toxicities and Risks of DMARDs

What is a common side effect of Leflunomide?

Diarrhea and elevated liver enzymes.

p.1
Mechanism of Action of DMARDs

What is the mechanism of action of Cyclosporine?

Inhibits IL1 and IL2 receptor.

p.2
Biologic DMARDs: Abatacept, Rituximab, and Tocilizumab

What does Rituximab target?

CD20 B lymphocytes.

p.3
Toxicities and Risks of DMARDs

What infections may TNF-alpha blockers reactivate?

Latent TB and Hepatitis B.

p.1
Mechanism of Action of DMARDs

What is the mechanism of action of Azathioprine?

Forms 6-thioguanine, which suppresses T and B cell function.

p.3
Considerations for DMARD Therapy in Special Populations

What should be done with the dosage of IL-1 inhibitors in patients with renal insufficiency?

Reduce the dosage.

p.1
Toxicities and Risks of DMARDs

What rescue agent is used with Cyclophosphamide?

MESNA.

p.2
Uses of Conventional Synthetic DMARDs

What conditions is Abatacept used for?

Rheumatoid arthritis and psoriatic arthritis.

Study Smarter, Not Harder
Study Smarter, Not Harder